PDF file: 451-0464_clinical_trial_data.pdf OPQ ID: 451-0464 Session: 451 Question number: Q-0464 Sessional paper: Q-464 Title: clinical trial data Short description: Topic: vaccines Identified concern: Keywords: Agencies: HC Date asked: 2022-04-04 Date tabled: Submitted by: Mr. Carrie (Oshawa) Reply by: Minister of Health Réponse de la ministre de la Santé Responded by: Mr. van Koeverden Pages: 6 Status: not processed Alert: yellow Questions asked: 4 Questions answered: 3 Percent responded: 75% Referenced sources: Canada.ca, COVID-19 vaccines and treatments portal Referenced links: https://bit.ly/3EH07IB, https://bit.ly/3lo1svI, https://bit.ly/3GFvDHE, https://bit.ly/3uEsNQFSummary, https://bit.ly/3GNlhWg, https://covid-vaccine.canada.ca/info/post-authorization-activity-table.html?linkID=SBD00510.In, https://health-infobase.canada.ca/covid-19/vaccine-safety/ Official link: https://www.google.com/search?q=Q-464+ourcommons.ca PDF URL: https://ivim.ca/foi/opq/r/451-0464_clinical_trial_data.pdf TXT URL: https://ivim.ca/foi/opq/r/451-0464.txt Original filename: Q-464, clinical trial data.pdf Local source path: C:\Users\Dmitry\Documents\CODES\OPQ-App\data-raw\OPQ\ALL OPQ TO DATE\2025\Q-464, clinical trial data.pdf Machine extracted at: 2026-06-30 12:58:31 References / links: - https://bit.ly/3EH07IB.For - https://bit.ly/3lo1svI(a - https://bit.ly/3GFvDHE - https://bit.ly/3uEsNQFSummary - https://bit.ly/3GNlhWg(b - https://covid-vaccine.canada.ca/info/post-authorization-activity-table.html?linkID=SBD00510.In - https://health-infobase.canada.ca/covid-19/vaccine-safety/(c - Canada.ca - COVID-19 vaccines and treatments portal Machine notes: (none) Question text preview: With regard to data held by the government related to Pfizer’s COVID-19 vaccine: (a) on what date and how was the government informed of the clinical trial data of the vaccine that was published on November 4, 2021, in the New England Journal of Medicine; (b) on what date and how was the government informed of the adverse reactions and side effects of the vaccine as mentioned in the documents released in accordance with the order made by Justice Mark Pittman of the United States District Court for the Northern District of Texas on January 6, 2022; and (c) is the government aware of any additional data that will be released by Pfizer this year, and if so, what are the details, including the (i) date the government became aware of the data, (ii) date the data will become public, (iii) summary of data findings?